115 related articles for article (PubMed ID: 15611430)
1. Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
Coras B; Hafner C; Reichle A; Hohenleutner U; Szeimies RM; Landthaler M; Vogt T
Arch Dermatol; 2004 Dec; 140(12):1504-7. PubMed ID: 15611430
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors.
Vogt T; Hafner C; Bross K; Bataille F; Jauch KW; Berand A; Landthaler M; Andreesen R; Reichle A
Cancer; 2003 Nov; 98(10):2251-6. PubMed ID: 14601096
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Reichle A; Bross K; Vogt T; Bataille F; Wild P; Berand A; Krause SW; Andreesen R
Cancer; 2004 Nov; 101(10):2247-56. PubMed ID: 15470711
[TBL] [Abstract][Full Text] [Related]
4. Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
Reichle A; Vogt T; Coras B; Terheyden P; Neuber K; Trefzer U; Schultz E; Berand A; Bröcker EB; Landthaler M; Andreesen R
Melanoma Res; 2007 Dec; 17(6):360-4. PubMed ID: 17992118
[TBL] [Abstract][Full Text] [Related]
5. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
Dezube BJ; Pantanowitz L; Aboulafia DM
AIDS Read; 2004 May; 14(5):236-8, 243-4, 251-3. PubMed ID: 15199854
[TBL] [Abstract][Full Text] [Related]
6. [Update on Kaposi's sarcoma].
Morand JJ; Lightburn E; Simon F; Patte JH
Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous tumors, massive lymphadenopathy, and secondary lymphedema in a 16-year-old boy--quiz case. African/endemic Kaposi sarcoma (KS): lymphadenopathic form.
Patel AR; Charles CA; Ricotti CA; Romanelli P; Connelly EA
Arch Dermatol; 2008 Sep; 144(9):1217-22. PubMed ID: 18794470
[No Abstract] [Full Text] [Related]
8. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma.
Ben M'barek L; Fardet L; Mebazaa A; Thervet E; Biet I; Kérob D; Morel P; Lebbe C
Dermatology; 2007; 215(3):202-5. PubMed ID: 17823515
[TBL] [Abstract][Full Text] [Related]
11. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma in Nigeria.
Onunu AN; Okoduwa C; Eze EU; Adeyekun AA; Kubeyinje EP; Schwartz RA
Int J Dermatol; 2007 Mar; 46(3):264-7. PubMed ID: 17343581
[TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma after kidney transplantation.
Einollahi B
Iran J Kidney Dis; 2007 Jul; 1(1):2-11. PubMed ID: 19357436
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions.
Caccialanza M; Marca S; Piccinno R; Eulisse G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):297-302. PubMed ID: 18269597
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
[TBL] [Abstract][Full Text] [Related]
17. A new therapeutic approach in patients with advanced sarcoma.
Kasper B; Ho AD; Egerer G
Int J Clin Oncol; 2005 Dec; 10(6):438-40. PubMed ID: 16369750
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
19. Classic Kaposi sarcoma mimicking chilblains.
Vano-Galvan S; Moreno C; Fernández-Lorente M; Jaén P
Dermatol Online J; 2011 Feb; 17(2):16. PubMed ID: 21382299
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
